Article references (48 references )

  1. Federal Ministry of Health. National Tuberculosis and Leprosy Control Programme; Department of Public Health. Worker's Manual. 2008; 5th Edition: 42.

  2. World Health Organization. Global HIV prevalence has levelled off. 2007. Accessed 20 January 2010.

  3. Obionu CN. Primary Health Care for developing countries. Institute for Developmental Studies, University of Nigeria, Enugu Campus, Enugu. Second Edition 2007; 139-150.

  4. Federal Ministry of Health. National Guidelines for HIV and AIDS Treatment and Care in Adolescents and Adults. Federal Ministry of Health Abuja, Nigeria. 2007; 1-4.

  5. World Health Organization. Adherence to long-term therapies: evidence for action. WHO. 2003; P3. Google Scholar

  6. Claxton AJ, Cramer J, Pierce CA. Systematic review of the associations between dose regimens and medication compliance. Clinical Therapy. 2001; 23(8): 1296-310. PubMed | Google Scholar

  7. Rudd P, Byyny RI, Zachary V. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens. 1988 Jul; 1(3 Pt 1): 309-12. PubMed | Google Scholar

  8. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5): 487-97. PubMed | Google Scholar

  9. Bangsberg DR. Adherence to protease inhibitors, HIV-1 viral load and development of drug resistance in an indigent population. AIDS. 2000; 14(4): 357-366. PubMed | Google Scholar

  10. Montaner JSG. A randomized, double-blind trial comparing combinations of navirapine, didanosine and zidovudine for HIV-infected patients: the INCAS Trial. JAMA. 1998; 279(12): 930-937. PubMed | Google Scholar

  11. Paterson DL. Adherence to protease inhibitors therapy and outcome in patients with HIV infection. Annals of Internal Medicine. 2000; 133(1): 21-30. PubMed | Google Scholar

  12. Federal Ministry of Health. National HIV Seroprevalence Sentinel Survey. Abuja: Federal Ministry of Health. 2005.

  13. World Health Organization. WHO African Region: Nigeria. 2008.

  14. Avert. HIV and AIDS in Africa. Accessed 20 January 2010.

  15. Dlamini PS, Wantland D, Makoae LN et al. HIV stigma and missed medication in HIV- positive people in five African countries. AIDS Patient Care STDs. 2009; 23(5): 377-389. PubMed | Google Scholar

  16. Iliyasu Z, Kabir M, Abubakar IS et al. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano Nigeria. Niger J Med. 2005; 14(3): 290-4. PubMed | Google Scholar

  17. Shaahu VN, Lawoyin TO, Sangowawa AO. Adherence to highly active antiretroviral therapy (cART) at a Federal Medical Centre. Afr J Med Sci. 2008; 37(1): 29-36. PubMed

  18. Van Leeumen R, Katlama C, Murphy RL. A randomized trial to study first line combination therapy with or without a protease inhibitor in HIV-1 infected patients. AIDS. 2003 May 2; 17(7): 987-99. PubMed | Google Scholar

  19. Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, Bangsberg DR. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PloS one. 2008; 3(7): e2783. PubMed | Google Scholar

  20. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clinical Infection Diseases. 2000; 30: S171-S176. PubMed | Google Scholar

  21. Medley A, Garcia-Moreno C, McGill S et al. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implication for prevention of mother-to-child transmission programmes. Bull World Health organ. 2004; 82(4): 299-307. PubMed | Google Scholar

  22. Rao D, Kekwaletswe TC, Hoseks S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youths living with HIV. AIDS Care. 2007; 19(1): 28-33. Google Scholar

  23. Adelekan NL, Olayemi EJ, Ndom J. Caring for people with AIDS in Nigeria Teaching Hospitals. Staff attitude and knowledge. AIDS Care. 1995; 7 Suppl 1: S63-72. PubMed | Google Scholar

  24. Wolfe WR, Weisser SD, Bangsberg DR. Effects of HIV related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. 2006; 18(8): 931-933. PubMed | Google Scholar

  25. Nachega JB, Stain DM, Lehman D. Adherence to Antiretroviral Therapy in HIV-Infected Adults in Soweto, South Africa. 2004; 20(10): 1053-1056. PubMed | Google Scholar

  26. Oloowokere SA, Fatiregun AA, Akinyemi JO et al. Prevalence and determinants of non-adherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria. J Infect Dev Cties. 2008; 2(5): 369-72. PubMed | Google Scholar

  27. Erah PO, Arute JE. Adherence of HIV/AIDS patients to antiretroviral in a tertiary health facility in Benin City. African Journal of pharmacy and pharmacology. 2008; 2(7): 142-152. Google Scholar

  28. Talam NC, Gatongi P, Rotich J, Kimaiyo S. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital Eldoret, Kenya. East Afr J Public Health. 2008; 5(2): 74-8. PubMed | Google Scholar

  29. Uzochukwu BS, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, Chukwuogo OI. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health policy and planning. 2009; 24(3): 189-96. PubMed | Google Scholar

  30. Mannheimer SB, Matts J, Telzak E et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005; 17(1): 10-22. PubMed | Google Scholar

  31. Murphy DA, Sarr M, Durako SJ. Barriers to HAART among Human Immunodeficiency Virus infected adolescents. Arch Paediatr Adolesc Med. 2003; 157(3): 249-55. PubMed | Google Scholar

  32. Abel E, Painter L. Factors that influence adherence to HIV medications: perception of women and health care providers. J Association Nurses. AIDS Care. 2003; 14(4): 61-67. PubMed | Google Scholar

  33. Murphy D, Johnson RK, Martin DJ. Barriers to antiretroviral adherence among HIV infected adults. AIDS Patient Care STDs. 2000; (14)1: 47-58. PubMed | Google Scholar

  34. Malcom S, Ng JJ, Rosen RK et al. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care. 2003; (15)2: 251-261. PubMed | Google Scholar

  35. Golin C, Isasi F, Bontempi JB et al. Secret pills: HIV-positive patients' expenses taking antiretroviral therapy in North Carolina. AIDS Educ Prev. 2002; 14(4): 318-329. Google Scholar

  36. Adam B, Maticka-Tyndale E, Cohen JJ. Adherence practices among people living with AIDS. AIDS Care. 2003; 15(2): 263-274. PubMed | Google Scholar

  37. Van Servellen G, Brown JS, Lombardi E et al. Health literacy in low-income Latino men and women receiving antiretroviral therapy in community based treatment centre. AIDS patient Care STDs. 2003; 17(6):283-98. PubMed | Google Scholar

  38. Chesney MA. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000; 12(3): 255-266. PubMed | Google Scholar

  39. Gordillo V. Socio-demographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999; 13(13): 1763-1769. PubMed | Google Scholar

  40. Macroft A. A comparison of exposure groups in the Eurosida Study: Starting highly active antiretroviral therapy HAART), response to HAART and survival. Journal of Acquired Immunodeficiency Syndrome. 1999; 22(4): 369-378. PubMed | Google Scholar

  41. Weiser S, Wolfe W, Bangsberg D et al. Barriers to antiretroviral adherence for patients living with HIV/AIDS in Botswana. J Acquir Immunodeficiency Syndrome. 2003; 34(3): 281-288. PubMed | Google Scholar

  42. Brigido L, Rodrigues R, Cassels J et al. Impact of adherence to antiretroviral therapy in HIV-1 infected patients at a University Public Service in Brazil. AIDS patient Care STDs. 2001; 15(11): 587-593. PubMed | Google Scholar

  43. Salami AK, Fadeyi A, Ogunmodede JA et al. Factors influencing adherence to antiretroviral medication in Ilorin, Nigeria. Journal of International Association of Physicians in AIDS Care. 2010; 9(3): 191-195. PubMed | Google Scholar

  44. Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, Ibanga I, Ajayi S, Eng M, Mondal P, Gebi U. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PloS one. 2010; 5(5): e10584. PubMed | Google Scholar

  45. Bond W, Hussar DA. Detection of methods and strategies for improving medication compliance. American journal of public health. 1991; 48(9): 1978-88. PubMed | Google Scholar

  46. Christensen AJ, Smith TW. Personality and patience adherence correlates of the five factor model in renal dialysis. J Behav Med. 1995; 18(3): 305-13. PubMed | Google Scholar

  47. Mills EJ, Nachega JB, Buchan I. Adherence to antiretroviral therapy in Sub-Saharan Africa and North America: A meta-analysis. JAMA. 2006; 296(6): 679-690. PubMed | Google Scholar

  48. Yu JK, Chen SC, Wang KY. True outcomes for patients on antiretroviral therapy who are "lost to follow up" in Malawi. Bulletin of world Health Organization. 2007; 85(7): 550-554. PubMed | Google Scholar